Project Details
Description
A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating the Efficacy and Safety of Empasiprubart Versus Intravenous Immunoglobulin (IVIg) in Adults With Multifocal Motor Neuropathy
| Status | Active |
|---|---|
| Effective start/end date | 1/1/25 → 12/31/30 |
Funding
- ARGENX BV
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.